Andrew Spaventa
2022
In 2022, Andrew Spaventa earned a total compensation of $4.7M as Chief Executive Officer and Chair of the Board at Singular Genomics Systems, a 598% increase compared to previous year.
Compensation breakdown
| Bonus | $159,000 |
|---|---|
| Option Awards | $4,042,863 |
| Salary | $520,833 |
| Other | $6,100 |
| Total | $4,728,796 |
Spaventa received $4M in option awards, accounting for 85% of the total pay in 2022.
Spaventa also received $159K in bonus, $520.8K in salary and $6.1K in other compensation.
Rankings
In 2022, Andrew Spaventa's compensation ranked 688th out of 5,760 executives tracked by ExecPay. In other words, Spaventa earned more than 88.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 688 out of 5,760 | 88th |
Division Manufacturing | 303 out of 3,136 | 90th |
Major group Measuring, Analyzing, And Controlling Instruments; Photographic, Medical And Optical Goods; Watches And Clocks | 28 out of 485 | 94th |
Industry group Laboratory Apparatus And Analytical, Optical, Measuring, and Controlling Instruments | 9 out of 108 | 92nd |
Industry Laboratory Analytical Instruments | 7 out of 46 | 85th |
Source: SEC filing on April 13, 2023.
Spaventa's colleagues
We found two more compensation records of executives who worked with Andrew Spaventa at Singular Genomics Systems in 2022.